About
Samuel Ohayon is Managing Partner at Glen Ventures and Entrepreneur in Residence at CTS, focusing on early-stage health technology investments. His background spans translational research, biotech entrepreneurship, and digital health executive roles, providing multi-disciplinary expertise across the healthcare value chain. He works on venture building, value creation, and strategic partnerships in the biomedical sector.
Experience
- Glen VenturesManaging Partnercurrent2024 — presentMontreal, Quebec, Canada
- Paratus MedicalInvestor & Board Observercurrent2025 — presentMontreal, QC
- Leaflet SolutionsInvestor & Board Obsevercurrent2025 — presentMontreal, Quebec, Canada
- Sensifai HealthInvestor & Board membercurrent2025 — present
- Paperplane Therapeutics Virtual RealityInvestor & Board Membercurrent2025 — present
- Paperplane Therapeutics Virtual RealityStrategic Advisor2021 — 2024
- Health Technology Catalyst | CTSEntrepreneur In Residencecurrent2021 — presentMontreal, Quebec, Canada
- KiroStrategic Advisorcurrent2021 — presentParis, Île-de-France, France
- TherAppXBoard Observercurrent2022 — present
- NexPlasmaGenStrategic Advisorcurrent2022 — presentMontreal, Quebec, Canada
- Ditch LabsStrategic Advisorcurrent2021 — presentMontreal, Quebec, Canada
- Kento HealthStrategic Advisor2023 — 2025Montreal, Quebec, Canada
- ScrubChart.AIStrategic Advisor2022 — 2025Montreal, Quebec, Canada
- NeuroServoStrategic Advisor2021 — 2024Montreal, Quebec, Canada
- Montréal inc.Volunteer Coach & Mentor2021 — 2024Montreal, Quebec, Canada
- MEDXLABDirector2020 — 2021Montreal, Quebec, Canada
- Donisi HealthStrategic Partnership Director, North America2019 — 2020Montreal, Canada Area
- SMOHealth and Life Science Technologies Commercialization Consultant2017 — 2019Montreal, Canada Area
- SciCeptionCo-Founder2016 — 2018Montreal, Canada Area
- Montreal Jewish General HospitalResearch Associate Ageing Biology2014 — 2017Montreal, Canada Area
Education
- Massachusetts Institute of TechnologyHealth Innovation Bootcamp - Digital Health2020
- Harvard Medical SchoolHealth Innovation Bootcamp - Digital Health2020
- McGill UniversityMaster of Science - MS, Molecular Pathology2011 — 2014
- Université de MontréalBachelor of Science (BS), Biochemistry and Molecular Medicine2007 — 2011
- Pierre and Marie Curie UniversityMedicine2004 — 2007
- Pierre and Marie Curie UniversityPhysics2003 — 2004
- Lycée Hélène Boucher2000 — 2003
Skills & more
Healthcare Information Technology (HIT)2Entrepreneurship2Digital Health1Medical TechnologyVenture CapitalFundraisingEarly Stage VenturesManagement4Innovation ManagementLife Sciences3Biotechnology12Molecular Biology1
+12 more
Cell BiologyOncologyBusiness DevelopmentProject ManagementPharmaceutical IndustryStrategic PartnershipsBusiness Relationship ManagementPublic SpeakingenglishfrenchLeadershipStrategic PlanningLanguages English · French · Hebrew · Spanish
From Samuel's professional profile.
Same school
Also attended Massachusetts Institute of Technology977
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 971 more
Also attended Harvard Medical School118
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 112 more
Also attended Université de Montréal40
Anne-Sophie GauvinCommunications & Office Manager at Luge CapitalJyri EngeströmPartner at Lifeline VenturesRajaa GrarVenture Partner at Springdale VenturesErich SieberFounding General Partner at PeakBridge VCFrancois GrattonInvestor at AgeTech CapitalSasha LuccioniInvestor at Blue Tulip Ventures
+ 34 more
